231 related articles for article (PubMed ID: 27334330)
21. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
[TBL] [Abstract][Full Text] [Related]
22. Autosomal dominant hypocalcemia due to a truncation in the C-tail of the calcium-sensing receptor.
Maruca K; Brambilla I; Mingione A; Bassi L; Capelli S; Brasacchio C; Soldati L; Cisternino M; Mora S
Mol Cell Endocrinol; 2017 Jan; 439():187-193. PubMed ID: 27561204
[TBL] [Abstract][Full Text] [Related]
23. Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcaemia and literature review.
Thim SB; Birkebaek NH; Nissen PH; Høst C
Acta Paediatr; 2014 Nov; 103(11):1117-25. PubMed ID: 25039540
[TBL] [Abstract][Full Text] [Related]
24. Extrapyramidal symptoms and advanced calcification of the basal ganglia in a patient with autosomal dominant hypocalcemia.
Kurozumi A; Okada Y; Arao T; Endou I; Matsumoto T; Tanaka Y
Intern Med; 2013; 52(18):2077-81. PubMed ID: 24042516
[TBL] [Abstract][Full Text] [Related]
25. Bone Matrix Mineralization in Patients With Gain-of-Function Calcium-Sensing Receptor Mutations Is Distinctly Different From that in Postsurgical Hypoparathyroidism.
Ovejero D; Misof BM; Gafni RI; Dempster D; Zhou H; Klaushofer K; Collins MT; Roschger P
J Bone Miner Res; 2019 Apr; 34(4):661-668. PubMed ID: 30496603
[TBL] [Abstract][Full Text] [Related]
26. Clinical characterization of a novel calcium sensing receptor genetic alteration in a Greek patient with autosomal dominant hypocalcemia type 1.
Papadopoulou A; Gole E; Melachroinou K; Trangas T; Bountouvi E; Papadimitriou A
Hormones (Athens); 2017 Apr; 16(2):200-204. PubMed ID: 28742508
[TBL] [Abstract][Full Text] [Related]
27. Diseases associated with calcium-sensing receptor.
Vahe C; Benomar K; Espiard S; Coppin L; Jannin A; Odou MF; Vantyghem MC
Orphanet J Rare Dis; 2017 Jan; 12(1):19. PubMed ID: 28122587
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms.
Alvarez-Hernández D; Santamaría I; Rodríguez-García M; Iglesias P; Delgado-Lillo R; Cannata-Andía JB
J Mol Endocrinol; 2003 Oct; 31(2):255-62. PubMed ID: 14519094
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635).
Roberts MS; Gafni RI; Brillante B; Guthrie LC; Streit J; Gash D; Gelb J; Krusinska E; Brennan SC; Schepelmann M; Riccardi D; Bin Khayat ME; Ward DT; Nemeth EF; Rosskamp R; Collins MT
J Bone Miner Res; 2019 Sep; 34(9):1609-1618. PubMed ID: 31063613
[TBL] [Abstract][Full Text] [Related]
30. GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts.
Mayr B; Schnabel D; Dörr HG; Schöfl C
Eur J Endocrinol; 2016 May; 174(5):R189-208. PubMed ID: 26646938
[TBL] [Abstract][Full Text] [Related]
31. GNA11 Variants Identified in Patients with Hypercalcemia or Hypocalcemia.
Howles SA; Gorvin CM; Cranston T; Rogers A; Gluck AK; Boon H; Gibson K; Rahman M; Root A; Nesbit MA; Hannan FM; Thakker RV
J Bone Miner Res; 2023 Jun; 38(6):907-917. PubMed ID: 36970776
[TBL] [Abstract][Full Text] [Related]
32. Autosomal Dominant PTH Gene Signal Sequence Mutation in a Family With Familial Isolated Hypoparathyroidism.
Cinque L; Sparaneo A; Penta L; Mencarelli A; Rogaia D; Esposito S; Fabrizio FP; Baorda F; Verrotti A; Falorni A; Stangoni G; Hendy GN; Guarnieri V; Prontera P
J Clin Endocrinol Metab; 2017 Nov; 102(11):3961-3969. PubMed ID: 28938448
[TBL] [Abstract][Full Text] [Related]
33. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.
Okazaki R; Chikatsu N; Nakatsu M; Takeuchi Y; Ajima M; Miki J; Fujita T; Arai M; Totsuka Y; Tanaka K; Fukumoto S
J Clin Endocrinol Metab; 1999 Jan; 84(1):363-6. PubMed ID: 9920108
[TBL] [Abstract][Full Text] [Related]
34. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.
Pearce SH; Williamson C; Kifor O; Bai M; Coulthard MG; Davies M; Lewis-Barned N; McCredie D; Powell H; Kendall-Taylor P; Brown EM; Thakker RV
N Engl J Med; 1996 Oct; 335(15):1115-22. PubMed ID: 8813042
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
[TBL] [Abstract][Full Text] [Related]
36. Autosomal dominant hypocalcemia with a novel
Wu Y; Zhang C; Huang X; Cao L; Liu S; Zhong P
J Int Med Res; 2022 Jul; 50(7):3000605221110489. PubMed ID: 35818129
[TBL] [Abstract][Full Text] [Related]
37. Autosomal dominant hypocalcaemia: identification of two novel variants of
Gomes V; Silvestre C; Ferreira F; Bugalho MJGM
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32513763
[TBL] [Abstract][Full Text] [Related]
38. Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?
Yamamoto M; Akatsu T; Nagase T; Ogata E
J Clin Endocrinol Metab; 2000 Dec; 85(12):4583-91. PubMed ID: 11134112
[TBL] [Abstract][Full Text] [Related]
39. A G-protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2).
Gorvin CM; Cranston T; Hannan FM; Rust N; Qureshi A; Nesbit MA; Thakker RV
J Bone Miner Res; 2016 Jun; 31(6):1200-6. PubMed ID: 26729423
[TBL] [Abstract][Full Text] [Related]
40. Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey.
Raue F; Pichl J; Dörr HG; Schnabel D; Heidemann P; Hammersen G; Jaursch-Hancke C; Santen R; Schöfl C; Wabitsch M; Haag C; Schulze E; Frank-Raue K
Clin Endocrinol (Oxf); 2011 Dec; 75(6):760-5. PubMed ID: 21645025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
